News and Updates

Explore the projected 11.2% growth of the Clinical Data Management System market through 2034 and the key drivers shaping the future of clinical research.

Discover how data analytics and AI are revolutionizing clinical trials, streamlining patient recruitment, and accelerating evidence-based drug development.

New research confirms that digital CBT programs effectively reduce anxiety and depression in patients with chronic illness, improving overall health outcomes.

A breakthrough mRNA cancer vaccine developed by Moderna and Merck shows promise in treating high-risk melanoma when combined with immunotherapy.

Explore the friction between AI innovation and FDA regulations as the medical industry faces challenges in deploying self-learning diagnostic software.

The Maradona trial is officially on hold as the court investigates potential medical evidence errors. Discover the impact on the ongoing negligence case.

Adaptin Bio has officially opened enrollment for its new Phase 1 clinical trial. Learn about the focus on safety, dosage, and future drug development.

A major error in Maradona's trial has emerged after experts analyzed the wrong medical records. Discover how this affects the negligence proceedings.

The FDA is developing new regulatory guidelines for Generative AI in medical devices, focusing on clinical safety, algorithmic bias, and lifecycle oversight.

Recent patient deaths in Chinese clinical trials have sparked concerns over regulatory oversight and the risks of prioritizing speed over safety in research.